|
CLTB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.06529999999161E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.44290000000525E-05 |
| Normal-vs-Stage2 |
4.059600E-03 |
| Normal-vs-Stage3 |
4.03149999994579E-06 |
| Normal-vs-Stage4 |
8.162000E-04 |
| Stage1-vs-Stage2 |
4.014000E-01 |
| Stage1-vs-Stage3 |
7.915500E-02 |
| Stage1-vs-Stage4 |
7.017800E-01 |
| Stage2-vs-Stage3 |
8.108800E-01 |
| Stage2-vs-Stage4 |
6.256000E-01 |
| Stage3-vs-Stage4 |
3.327000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.99369999995558E-06 |
| Normal-vs-AfricanAmerican |
5.160600E-03 |
| Normal-vs-Asian |
4.717100E-03 |
| Caucasian-vs-AfricanAmerican |
6.349000E-01 |
| Caucasian-vs-Asian |
8.630400E-01 |
| AfricanAmerican-vs-Asian |
7.728200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.70020000000992E-06 |
| Normal-vs-Female |
2.02769999999575E-05 |
| Male-vs-Female |
1.312630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.037890E-04 |
| Normal-vs-Age(41-60Yrs) |
2.43879999999308E-05 |
| Normal-vs-Age(61-80Yrs) |
1.644490E-04 |
| Normal-vs-Age(81-100Yrs) |
4.378300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.354400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.413000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.301800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.702600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.468800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.382400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.970600E-01 |
| Classical-VS-Follicular |
1.920000E-01 |
| Classical-VS-Other |
5.108000E-01 |
| Classical-VS-Normal |
2.06249999999963E-05 |
| Tall-VS-Follicular |
4.634400E-01 |
| Tall-VS-Other |
6.161600E-01 |
| Tall-VS-Normal |
4.164100E-02 |
| Follicular-VS-Other |
9.322000E-01 |
| Follicular-VS-Normal |
6.44169999999278E-05 |
| Other-VS-Normal |
1.167800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.26899999997043E-06 |
| Normal-vs-N1 |
1.859280E-03 |
| N0-vs-N1 |
7.136400E-01 |
|
|
